VectivBio AG – Trademark Portfolio
Entity Type: 25
VectivBio AG holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 12 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include APTYCA, KYNPRI, VECTIV, and ZAVRYK.
Aeschenvorstadt 36
CH-4051 Basel
Showing of trademarks Trademarks
Trademark Classifications
VectivBio AG's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does VectivBio AG have?
VectivBio AG has 12 U.S. trademarks filed with the USPTO. Of these, 9 registered, 2 abandoned, 1 cancelled.
What trademark classes does VectivBio AG file in?
VectivBio AG files trademarks across 5 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are VectivBio AG's most well-known trademarks?
VectivBio AG's registered trademark portfolio includes well-known marks such as APTYCA, KYNPRI, VECTIV, and ZAVRYK. These are among 9 currently registered trademarks in the portfolio.
What is VectivBio AG's trademark registration success rate?
VectivBio AG has a 75% trademark registration rate, with 9 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.